Table 1. Participant characteristics.
All patients | No Current Depressive episode | Current Depressive episode | |
---|---|---|---|
n (%) | n (%) | n (%) | |
N (%) | 119 (100) | 51 (42.9) | 68 (57.1) |
Female | 102 (85.7) | 43 (84.3) | 59 (86.8) |
Male | 17 (14.3) | 8 (9) | 9 (13.2) |
Age (mean) | 21 | 21 | 21 |
BMI (mean) | 23.3 | 23.6 | 24.6 |
MADRS-S | 23.6 | 18.4 | 27.5 |
Diagnosis | |||
Unipolar disorder, single episode | 39 (32.8) | 10 (19.6) | 29 (42.6) |
Unipolar disorder, recurrent | 41 (34.5) | 18 (35.3) | 23 (33.8) |
Bipolar disorder, type 1 | 4 (3.4) | 2 (3.9) | 2 (2.9) |
Bipolar disorder, type 2 and unspecified | 25 (21.0) | 11 (21.7) | 14 (20.9) |
Any anxiety disorder | 79 (66.4) | 31 (60.8) | 49 (72.0) |
Medication* | |||
SSRI/SNRI** | 60 (50.4) | 25 (49.0) | 35 (51.5) |
Antipsychotics | 6 (5.0) | 4 (7.8) | 2 (2.9) |
Mood stabilizers | 8 (6.7) | 7 (13.7) | 1 (1.5) |
Oral Anticonception | 30 (25.2) | 17 (33.3) | 13 (19.1) |
* Treatment at the time of saliva sampling
** SSRI/SNRI: Selective serotonin re-uptake inhibitors/ Serotonin–norepinephrine re-uptake inhibitors